A new approach to analyzing metabolite levels in newborn blood samples decreases the likelihood of false-negatives and false-positives, according to results from a new study by Gregg Marquardt, MSS, from the Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, and colleagues. The study was published online February 16 in Genetics in Medicine.
Medscape, by Rick Lewis, PhD, 02/16/2012
Tags: Department of Laboratory Medicine and Pathology, Gregg Marquardt, Mayo Clinic College of Medicine, Mayo Clinic Rochester, metabolite levels, newborn blood samples, Pediatrics, Research